Deals

METiS TechBio Partners with Eli Lilly on AI‑Driven Lipid Nanoparticle Delivery – Up to USD 1.1 Billion in Milestones for Tissue‑Specific LNP Discovery
Eli LillyHKG: 7666

METiS TechBio Partners with Eli Lilly on AI‑Driven Lipid Nanoparticle Delivery – Up to USD 1.1 Billion in Milestones for Tissue‑Specific LNP Discovery

METiS TechBio (HKG: 7666), an innovative AI drug delivery company, announced a strategic collaboration with Eli Lilly and Company (NYSE: LLY) focused on the research and discovery of novel lipid…

Hansoh Pharma Strikes Second ADC Licensing Deal with Roche – USD 400 Million Upfront, Over USD 15 Billion in Potential Milestones

Hansoh Pharma Strikes Second ADC Licensing Deal with Roche – USD 400 Million Upfront, Over USD 15 Billion in Potential Milestones

Insilico Medicine Earns Milestone Payment from Servier – First Oncology Program Hits Early‑Stage Drug Discovery Mark on Pharma.AI Platform

Insilico Medicine Earns Milestone Payment from Servier – First Oncology Program Hits Early‑Stage Drug Discovery Mark on Pharma.AI Platform

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics
BiotechETR: MRK

Merck KGaA Nears Completion of $3.5 Billion Acquisition of SpringWorks Therapeutics

CN Bio and Pharmaron Partner to Validate and Expand OOC Technology Applications
CN BioCRO / CMO / CDMO

CN Bio and Pharmaron Partner to Validate and Expand OOC Technology Applications

Shineco Inc. Announces Acquisition of InfiniClone for Regenerative Medicine Expansion
BiotechFinance

Shineco Inc. Announces Acquisition of InfiniClone for Regenerative Medicine Expansion

Shenzhen Core Medical Closes Series D Round to Advance Miniaturized Artificial Hearts
Core Medical TechnologyCVD

Shenzhen Core Medical Closes Series D Round to Advance Miniaturized Artificial Hearts

Show More